Novo Nordisk A/S seeks an initial public offering of NNIT A/S
- Company announcement 5/2015:Initial public offering of NNIT A/S priced at DKK 125 per offer share
- Company announcement 3/2015: Early close of offering of shares
- Company announcement 2/2015: Increase of the indicative offer price range
- Supplement to prospectus (new indicative offer price range)
- Company announcement 1/2015: NNIT publishes prospectus and indicative price range
- Press release: Novo Nordisk A/S seeks an initial public offering of NNIT A/S
- Press release: NNIT financial report for 2014
- NNIT annual report 2014
- Selskabsmeddelelse 5/2015: Udbudskursen i forbindelse med børsnoteringen af aktierne i NNIT A/S fastsættes til 125 kr. pr. udbudt aktie
- Selskabsmeddelelse 3/2015: Tidlig lukning af udbud af aktier
- Selskabsmeddelelse 2/2015: Forhøjelse af det indikative udbudskursinterval
- Prospekttillæg (nyt indikativt udbudskursinterval)
- Selskabsmeddelelse 1/2015: NNIT offentliggør prospekt og indikativt kursinterval
- Brochure NNIT går på børsen
- Pressemeddelelse Novo Nordisk AS søger børsnotering af NNIT AS
- Pressemeddelelse NNIT Årsregnskab 2014
THE ACCESS TO THE INFORMATION AND DOCUMENTS CONTAINED IN THIS SECTION OF THE WEBSITE OF NNIT A/S (THE "COMPANY") IS LIMITED TO PERSONS RESIDENT AND PHYSICALLY PRESENT IN DENMARK AND TO AUTHORISED PERSONS WHO ARE RESIDENT AND PHYSICALLY PRESENT IN CERTAIN OTHER JURISDICTIONS. THE INFORMATION IS MADE AVAILABLE IN CONNECTION WITH THE INITIAL PUBLIC OFFERING OF SHARES IN THE COMPANY WHICH COMPRISES (I) A PUBLIC OFFERING TO RETAIL AND INSTITUTIONAL INVESTORS IN DENMARK, (II) A PRIVATE PLACEMENT IN THE UNITED STATES ONLY TO PERSONS WHO ARE "QUALIFIED INSTITUTIONAL BUYERS" OR "QIBS" (AS DEFINED IN RULE 144A UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) IN RELIANCE ON RULE 144A, AND (III) PRIVATE PLACEMENTS TO INSTITUTIONAL INVESTORS IN CERTAIN OTHER JURISDICTIONS. THE OFFERING OUTSIDE THE UNITED STATES WILL BE MADE IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT. THE INFORMATION AND DOCUMENTS MUST NOT BE ACCESSED, COPIED OR DOWNLOADED, IN WHOLE OR IN PART, BY PERSONS PRESENT OR RESIDENT IN ANY JURISDICTION WHERE AN OFFER TO SELL OR A SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES ISSUED BY THE COMPANY WOULD BE UNLAWFUL AND THE INFORMATION AND DOCUMENTS CONTAINED HEREIN ARE NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO SUCH JURISDICTIONS.
All persons residing outside of Denmark who wish to have access to the information and the docu-ments contained in this section of the Company’s website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained outside Denmark. The Company assumes no responsibility if there is a violation of applicable law or regulations by any person. In any member state of the European Economic Area ("EEA member state"), other than Denmark, that has implemented Directive 2003/71/EC as amended (together with any applicable implementing measures in any member state, the "Prospectus Directive"), the information and the documents contained in this section of the Company’s website are only addressed to and is only directed at investors in that EEA Member State who fulfil the criteria for exemption from the obligation to publish an offering circular, including qualified investors within the meaning of the Prospectus Directive as implemented in each such EEA Member State.
Any securities referred to in this section of the Company’s website have not been and will not be registered under the Securities Act, and may not be offered or sold in the United States absent registration or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A.
In the United Kingdom, the information and the documents contained in this section of the Com-pany’s website are only being distributed to, and are only directed at, and any investment or in-vestment activity to which this section of the Company’s website relates is available only to, and will be engaged in only with, "qualified investors" (as defined in section 86(7) of the Financial Services and Markets Act 2000) and who are (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). Persons who are not relevant persons should not take any action on the basis of the information and the documents contained in this section of the Company’s website and should not act or rely on them.
THE CONTENTS OF THIS SECTION OF THE WEBSITE ARE NOT TO BE INCORPORATED INTO, OR CONSTRUED TO FORM PART OF, ANY OF THE DOCUMENTS INCLUDED HEREIN. EXCEPT AS OTHERWISE EXPLICITLY STATED HEREIN AS APPLICABLE TO THEM, NO INFORMATION INCLUDED ON THIS SECTION OF THE WEBSITE SHOULD BE USED BY INVESTORS IN FORMING THEIR INVESTMENT DECISION AS TO ANY SECURITIES.